Literature DB >> 16882031

Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1.

Isabelle I Salles1, Daniel E Voth, Sabrina C Ward, Kathleen M Averette, Rodney K Tweten, Kenneth A Bradley, Jimmy D Ballard.   

Abstract

Anthrax toxin protective antigen (PA) binds cell surface receptors (e.g. ANTXR1,2), forms heptameric pores, and translocates lethal factor (LF) or oedema factor (OF) into the cytoplasm of mammalian cells. In the current study, we sought to determine how receptor levels influence these events, by examining PA heptamer stability and related processes in macrophages that overexpress ANTXR1 (RAW 264.7ANTXR1). In these experiments, PA-oligomers demonstrated an extended half-life in RAW 264.7ANTXR1 macrophages, with SDS-resistant heptamers detected up to 10 h following treatment, while levels of PA-oligomers declined within 3 h in control cells. RAW 264.7ANTXR1 macrophages were also more sensitive to lethal toxin, a combination of PA and LF. Surprisingly, we found that PA alone was cytotoxic to RAW 264.7ANTXR1 cells. Further analysis found that PA cytotoxicity required direct interaction with ANTXR1, oligomerization, channel formation, endosomal acidification, and was independent of the ANTXR1 cytoplasmic tail. PA intoxication of RAW 264.7ANTXR1 macrophages resulted in caspase-3 activation, with corresponding DNA fragmentation and proteolytic cleavage of poly-ADP-ribose polymerase, as well as activation of Bid, suggesting cell death occurred via apoptosis. Overall, results from the current study suggest that receptor levels dictate the extent of PA oligomer stability, and shifts in this normal process can lead to cell death via apoptosis in the absence of toxin catalytic subunits.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882031     DOI: 10.1111/j.1462-5822.2006.00708.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  15 in total

1.  Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.

Authors:  Eric K Dumas; Lori Garman; Hannah Cuthbertson; Sue Charlton; Bassam Hallis; Renata J M Engler; Shyamal Choudhari; William D Picking; Judith A James; A Darise Farris
Journal:  Vaccine       Date:  2017-05-11       Impact factor: 3.641

Review 2.  Anthrax toxin protective antigen--insights into molecular switching from prepore to pore.

Authors:  James G Bann
Journal:  Protein Sci       Date:  2012-01       Impact factor: 6.725

3.  CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.

Authors:  T Scott Devera; Lindsay M Aye; Gillian A Lang; Sunil K Joshi; Jimmy D Ballard; Mark L Lang
Journal:  Infect Immun       Date:  2010-02-01       Impact factor: 3.441

4.  Inhibition of anthrax protective antigen outside and inside the cell.

Authors:  Marina V Backer; Vimal Patel; Brian T Jehning; Kevin P Claffey; Vladimir A Karginov; Joseph M Backer
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

5.  Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.

Authors:  Melissa L Nguyen; Sherry R Crowe; Sridevi Kurella; Simon Teryzan; Brian Cao; Jimmy D Ballard; Judith A James; A Darise Farris
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

6.  Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1.

Authors:  R J Ingram; A Harris; S Ascough; G Metan; M Doganay; L Ballie; E D Williamson; H Dyson; J H Robinson; S Sriskandan; D M Altmann
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

7.  CA-074Me protection against anthrax lethal toxin.

Authors:  Zachary L Newman; Stephen H Leppla; Mahtab Moayeri
Journal:  Infect Immun       Date:  2009-07-27       Impact factor: 3.441

8.  Toxicity of anthrax toxin is influenced by receptor expression.

Authors:  Sarah C Taft; Alison A Weiss
Journal:  Clin Vaccine Immunol       Date:  2008-07-02

9.  The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes.

Authors:  Melissa L Nguyen; Simon Terzyan; Jimmy D Ballard; Judith A James; A Darise Farris
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

10.  Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy.

Authors:  Sunil K Joshi; Gillian A Lang; Jason L Larabee; T Scott Devera; Lindsay M Aye; Hemangi B Shah; Jimmy D Ballard; Mark L Lang
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.